Grantham, Mayo, Van Otterloo & Co (GMO)’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-141,300	Closed	-$19.8M	–	918
2020 Q3	$19.8M	Buy	+141,300	New	+$17.2M	0.14%	91

Grantham, Mayo, Van Otterloo & Co (GMO)'s LVGO Position: Q4 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 141,300 shares — an estimated $19.8M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LVGO in Q3 2020 and held it in 1 quarter. The position peaked at $19.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 141,300 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $19.8M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Livongo Health, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Livongo Health, Inc. Common Stock position peaked at $19.8M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2020, filed 12 Feb 2021.